A substance marketed to enhance, now forbidden to use
In the wake of at least four deaths tied to gluteal augmentation procedures, Brazil's Federal Council of Medicine has drawn a firm line between the pursuit of beauty and the preservation of life, banning the synthetic filler PMMA from all cosmetic and reconstructive use nationwide. The prohibition, effective Tuesday, reflects a reckoning that accumulated slowly — one hospitalization, one bathroom floor, one collapsed patient — until the pattern could no longer be ignored. A narrow exception survives for HIV-related lipodystrophy treatment in accredited public health units, a concession to medicine's complexity even as it closes the door on aesthetic application. What remains open is the harder question: whether law alone can redirect desire, or whether enforcement will prove as fragile as the promises once made to the women who sought these procedures.
- At least four women died between 2024 and 2025 after PMMA gluteal injections — some within hours of leaving the clinic — exposing a pattern of fatal complications that regulators could no longer defer.
- The deaths sparked criminal investigation: a Pernambuco judge ordered the arrest of a physician linked to one fatality, signaling that legal accountability is now pursuing the medical community.
- Brazil's Federal Council of Medicine responded with a near-total ban effective Tuesday, stripping clinics and practitioners of any legal authority to administer PMMA for aesthetic purposes.
- One carefully bounded exception remains — HIV/AIDS lipodystrophy treatment in high-complexity public health units — drawing a deliberate line between therapeutic necessity and cosmetic desire.
- The unresolved tension is enforcement: whether the ban will hold in practice, or whether demand will push the procedure underground into the hands of practitioners willing to operate outside the law.
Brazil's Federal Council of Medicine announced on Friday, May 29th, a nationwide ban on PMMA — polymethylmethacrylate, a synthetic cosmetic filler — for all aesthetic and reconstructive procedures, effective Tuesday. The decision follows a series of deaths among women who underwent gluteal augmentation with the substance, a procedure marketed to enhance buttock volume.
The ban is nearly absolute. The sole surviving use is for lipodystrophy treatment in HIV and AIDS patients, and only within high-complexity units accredited by Brazil's public health system, following strict Health Ministry protocols. Every cosmetic application is now illegal.
The deaths that forced this reckoning accumulated over roughly eighteen months. Influencer Aline Ferreira died in 2024 after nine days of hospitalization following PMMA injections. In January 2025, Adriana Barros Lima Laurentino, forty-six, underwent the same procedure at a Recife clinic and was found dead in her bathroom hours after being discharged. A judge in Pernambuco later ordered the arrest of the physician under investigation in her case. On May 26th, Roseli Fernandes de Oliveira Romeiro Vieira collapsed at a São Paulo clinic the morning after her procedure and died.
The pattern was consistent: women seeking cosmetic enhancement, receiving injections, then experiencing sudden and catastrophic complications — intense pain, systemic reactions, organ failure. Resolution 2.461/2026 will be published in Brazil's Official Gazette on June 2nd, by which point the ban will already be in force. The harder question now is whether enforcement will match the regulation, and whether women who sought these procedures will find safer paths — or practitioners willing to work in the shadows.
Brazil's Federal Council of Medicine issued an official statement on Friday, May 29th, announcing a nationwide ban on PMMA—polymethylmethacrylate, a synthetic filler substance—for use in any cosmetic or reconstructive procedure. The prohibition takes effect Tuesday. The decision comes after a series of deaths among women who underwent gluteal augmentation using the material, a procedure marketed as a way to enhance buttock volume.
The ban is nearly absolute. The only permitted use of PMMA going forward is for treating lipodystrophy in patients living with HIV and AIDS, and only when the procedure is performed in high-complexity medical units accredited by Brazil's public health system and conducted according to protocols established by the Health Ministry. Every other application of the substance for aesthetic purposes is now illegal.
The catalyst for this action is a trail of deaths that accumulated over roughly eighteen months. In 2024, Aline Ferreira, a social media influencer, died after receiving PMMA injections into her buttocks. She spent nine days hospitalized as complications developed, but did not survive. In January 2025, Adriana Barros Lima Laurentino, forty-six years old, underwent the same procedure at a clinic in Recife. Hours after being discharged and returning home, she experienced severe pain. She was found dead in her bathroom. In April, a judge in Pernambuco ordered the arrest of Dr. Marcelo Alves Vasconcelos, who was under investigation in connection with Adriana's death. Most recently, on May 26th, Roseli Fernandes de Oliveira Romeiro Vieira collapsed at a medical office in São Paulo's south zone, the morning after undergoing gluteal filler treatment. She died.
The pattern is consistent: women seeking cosmetic enhancement through a procedure that promised volume and shape, receiving injections of a substance that the medical establishment now recognizes as too dangerous to permit. The complications appear suddenly—intense pain, systemic reactions, organ failure—and in these cases, proved fatal.
The formal regulation, Resolution 2.461/2026 from the Federal Council of Medicine, will be published in Brazil's Official Gazette on June 2nd. By then, the ban will already be in effect. Clinics and practitioners across the country will have no legal authority to administer PMMA for aesthetic purposes. The exception for HIV-related lipodystrophy acknowledges that in a controlled medical setting, treating a specific disease-related condition, the substance may have a role. But for the pursuit of cosmetic alteration—for the desire to change one's appearance—the substance is now forbidden. The question now is whether the ban will be enforced, and whether women seeking these procedures will turn to safer alternatives or to practitioners willing to work outside the law.
Notable Quotes
The ban applies to all cosmetic and reconstructive uses of PMMA, with the sole exception being treatment of lipodystrophy in HIV/AIDS patients within accredited high-complexity health system units.— Federal Council of Medicine
The Hearth Conversation Another angle on the story
Why did it take multiple deaths before the medical council acted? Wasn't the danger known earlier?
The danger may have been known in pockets—among some doctors, in some communities—but it took deaths of women whose cases became public, whose families spoke out, for the institution to move. That's how regulation often works. It's reactive, not preventive.
What happens to the doctors who performed these procedures? Are they being held accountable?
One doctor was arrested. But the system is slow. The women are dead. Accountability after the fact doesn't restore what was lost.
Will women stop seeking these procedures now that it's banned?
Some will. Others will find practitioners willing to work illegally, or travel to other countries where it's still permitted. A ban doesn't erase the desire for the procedure—it just pushes it underground.
Why is the exception for HIV lipodystrophy different? Isn't that also a cosmetic concern?
Lipodystrophy is a medical condition—a side effect of antiretroviral therapy that causes disfigurement and can affect quality of life and medication adherence. It's not about vanity; it's about treating disease. The distinction matters legally and ethically.
Do we know if these women were warned about the risks?
The source doesn't say. That's one of the questions that will likely emerge in investigations and lawsuits. Whether they were informed, whether they understood, whether the risks were minimized—those details will shape how we understand what happened.